Mary Harvey

Biochemistry, Genetics and Molecular Biology · Life Sciences

12h-index1.3kcitations22works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(17), Virology and Viral Diseases(13), Animal Virus Infections Studies(7), Respiratory viral infections research(2), Viral Infectious Diseases and Gene Expression in Insects(2)

Publications22 total

Purkinje Cell Morphology and Display Complexity in Manakins (Pipridae)
2018· 1 cited
Toxicology Study of Repeat Intracerebral Administration of a Measles Virus Derivative Producing Carcinoembryonic Antigen in Rhesus Macaques in Support of a Phase I/II Clinical Trial for Patients with Recurrent Gliomas
Human Gene Therapy·2008· 87 citedOpen Access
Pre-Clinical Data and Preliminary Patient Results of Intravenous MV-NIS To Treat Relapsed, Refractory Multiple Myeloma.
Blood·2007
Engineering Oncolytic Measles Virus to Circumvent the Intracellular Innate Immune Response
Molecular Therapy·2007· 82 citedOpen Access
In-111DAC Is a Novel Technique To Image Multiple Myeloma.
Blood·2006· 1 cited
The Use of a Tropism-Modified Measles Virus in Folate Receptor–Targeted Virotherapy of Ovarian Cancer
Clinical Cancer Research·2006· 83 citedOpen Access
Immunoglobulin G Antibody-Mediated Enhancement of Measles Virus Infection Can Bypass the Protective Antiviral Immune Response
Journal of Virology·2006· 62 citedOpen Access
A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer
Breast Cancer Research and Treatment·2006· 94 cited
Oncolytic virotherapy for targeting ovarian cancer using fully folate receptor targeted recombinant measles virus
Cancer Research·2006
297. Safety of Repeat Intracerebral Administration of MV-CEA in Rhesus Macaques in Support of a Phase I/II Clinical Trial for Patients with Recurrent Gliomas
Molecular Therapy·2006· 5 citedOpen Access
775. Folate Receptor Targeted Virotherapy of Ovarian Cancer Using a Tropism Modified Measles Virus
Molecular Therapy·2006Open Access
482. T Cells as Carriers for Systemic Measles Virotherapy of Multiple Myeloma
Molecular Therapy·2006Open Access
Interaction of Measles Virus Vectors with Auger Electron Emitting Radioisotopes.
Blood·2005· 1 cited
Interaction of measles virus vectors with Auger electron emitting radioisotopes
Biochemical and Biophysical Research Communications·2005· 28 cited
A Preclinical Large Animal Model of Adenovirus-Mediated Expression of the Sodium–Iodide Symporter for Radioiodide Imaging and Therapy of Locally Recurrent Prostate Cancer
Molecular Therapy·2005· 61 citedOpen Access
Fully retargeted measles viruses for cancer therapy
Cancer Research·2005
Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancer
Cancer Gene Therapy·2005· 67 cited
Rescue and propagation of fully retargeted oncolytic measles viruses
Nature Biotechnology·2005· 249 citedOpen Access
Antibody-targeted cell fusion
Nature Biotechnology·2004· 118 cited
Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter
Blood·2003· 320 cited
page 1 of 2Next →

Frequent Co-authors

Stephen J. Russell(15), Kah-Whye Peng(13), Suzanne Greiner(8), Takafumi Nakamura(6), Rae Myers(6), Roberto Cattaneo(5), Mark J. Federspiel(5), Kosei Hasegawa(5), David Dingli(4), Diane Soeffker(4), Sompong Vongpunsawad(3), Paula J. Zollman(3), Evanthia Galanis(3), Mariangela Figini(3), Elizabeth R. Bergert(3), Philip R. Greipp(2), Michael K. O’Connor(2), John C. Morris(2), James Krempski(2), Corey Raffel(2)